Oxcarbazepine Placebo-Controlled, Dose-Ranging Trial in Refractory Partial Epilepsy
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-12-01
著者
-
Elger Christian
Klinik Fur Epileptologie Rheinische Friedrich Wilhelms-universitat Bonn
-
Barcs Gabor
Orszagos Pszichiatriai Es Neurologiai Intezeo
-
SCARAMELLI Alejandro
Institute of Neurology, University Hospital, Hospital de Clinidas
-
WALKER Elizabeth
Department of Neurology, Auckland Public Hospital
-
STEFAN Hermann
Neurologische Klinik, Kopfklinik der Universitat Erlangen-Nurnberg
-
STURM Yvonne
Novartis Pharma AG
-
MOORE Alan
Novartis Pharma AG
-
FLESCH Gerard
Novartis Pharma AG
-
Stefan Hermann
Neurologische Klinik Kopfklinik Der Universitat Erlangen-nurnberg
-
Walker Elizabeth
Department Of Neurology Auckland Public Hospital
-
Scaramelli Alejandro
Instituto De Neurologia Hospital De Clinicas
-
Scaramelli Alejandro
Institute Of Neurology University Hospital Hospital De Clinidas
-
D'souza Joseph
Novartis Pharmaceuticals Corporation
関連論文
- Replication Analysis of a Putative Susceptibility Locus (EGI) for Idiopathic Generalized Epilepsy on Chromosome 8q24
- Oxcarbazepine Placebo-Controlled, Dose-Ranging Trial in Refractory Partial Epilepsy
- Ictal Pleasant Sensations : Cerebral Localization and Lateralization
- Sustained Efficacy and Long-term Safety of Oxcarbazepine : One-year Open-label Extension of a Study in Refractory Partial Epilepsy